CARETRUST REIT INC (CTRE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CTRE • US14174T1079

36.68 USD
+0.27 (+0.74%)
At close: Feb 3, 2026
36.68 USD
0 (0%)
After Hours: 2/3/2026, 8:08:54 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CTRE. CTRE was compared to 124 industry peers in the Diversified REITs industry. CTRE scores excellent on profitability, but there are some minor concerns on its financial health. CTRE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes CTRE very considerable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year CTRE was profitable.
  • In the past year CTRE had a positive cash flow from operations.
  • Of the past 5 years CTRE 4 years were profitable.
  • In the past 5 years CTRE always reported a positive cash flow from operatings.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.12%, CTRE belongs to the top of the industry, outperforming 94.35% of the companies in the same industry.
  • CTRE has a better Return On Equity (6.53%) than 75.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 4.58%, CTRE belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CTRE is above the industry average of 3.05%.
Industry RankSector Rank
ROA 5.12%
ROE 6.53%
ROIC 4.58%
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

  • With an excellent Profit Margin value of 60.84%, CTRE belongs to the best of the industry, outperforming 99.19% of the companies in the same industry.
  • CTRE's Profit Margin has improved in the last couple of years.
  • CTRE has a better Operating Margin (66.50%) than 100.00% of its industry peers.
  • CTRE's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 99.38%, CTRE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 66.5%
PM (TTM) 60.84%
GM 99.38%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTRE is destroying value.
  • CTRE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CTRE has been increased compared to 5 years ago.
  • CTRE has a better debt/assets ratio than last year.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • CTRE has an Altman-Z score of 4.71. This indicates that CTRE is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CTRE (4.71) is better than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.22 indicates that CTRE is not too dependend on debt financing.
  • CTRE has a better Debt to Equity ratio (0.22) than 97.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 4.71
ROIC/WACC0.53
WACC8.67%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • CTRE has a Current Ratio of 4.05. This indicates that CTRE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.05, CTRE belongs to the top of the industry, outperforming 92.74% of the companies in the same industry.
  • A Quick Ratio of 4.05 indicates that CTRE has no problem at all paying its short term obligations.
  • CTRE has a Quick ratio of 4.05. This is amongst the best in the industry. CTRE outperforms 92.74% of its industry peers.
Industry RankSector Rank
Current Ratio 4.05
Quick Ratio 4.05
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

9

3. Growth

3.1 Past

  • CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.28%, which is quite impressive.
  • Measured over the past years, CTRE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.30% on average per year.
  • CTRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.24%.
  • The Revenue has been growing by 12.64% on average over the past years. This is quite good.
EPS 1Y (TTM)90.28%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%66.67%
Revenue 1Y (TTM)59.24%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%71.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.76% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 30.36% on average over the next years. This is a very strong growth
EPS Next Y78.09%
EPS Next 2Y40.56%
EPS Next 3Y27.76%
EPS Next 5YN/A
Revenue Next Year53.72%
Revenue Next 2Y39.87%
Revenue Next 3Y30.36%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.77 indicates a quite expensive valuation of CTRE.
  • CTRE's Price/Earnings ratio is a bit cheaper when compared to the industry. CTRE is cheaper than 68.55% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CTRE to the average of the S&P500 Index (28.18), we can say CTRE is valued inline with the index average.
  • The Price/Forward Earnings ratio is 22.64, which indicates a rather expensive current valuation of CTRE.
  • Based on the Price/Forward Earnings ratio, CTRE is valued cheaper than 90.32% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.51. CTRE is around the same levels.
Industry RankSector Rank
PE 26.77
Fwd PE 22.64
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CTRE's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. CTRE is more expensive than 86.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.69
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • CTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CTRE has an outstanding profitability rating, which may justify a higher PE ratio.
  • CTRE's earnings are expected to grow with 27.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)2.37
EPS Next 2Y40.56%
EPS Next 3Y27.76%

5

5. Dividend

5.1 Amount

  • CTRE has a Yearly Dividend Yield of 3.61%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 6.98, CTRE is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.83, CTRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

  • The dividend of CTRE has a limited annual growth rate of 4.05%.
  • CTRE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As CTRE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.05%
Div Incr Years9
Div Non Decr Years9
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • CTRE pays out 89.87% of its income as dividend. This is not a sustainable payout ratio.
  • CTRE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP89.87%
EPS Next 2Y40.56%
EPS Next 3Y27.76%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CARETRUST REIT INC

NYSE:CTRE (2/3/2026, 8:08:54 PM)

After market: 36.68 0 (0%)

36.68

+0.27 (+0.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05
Earnings (Next)02-12
Inst Owners102.45%
Inst Owner Change-0.78%
Ins Owners0.34%
Ins Owner Change0.63%
Market Cap8.19B
Revenue(TTM)428.48M
Net Income(TTM)260.67M
Analysts83.53
Price Target41.51 (13.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly Dividend1.09
Dividend Growth(5Y)4.05%
DP89.87%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.91%
Min EPS beat(2)-4.24%
Max EPS beat(2)0.43%
EPS beat(4)2
Avg EPS beat(4)-2.07%
Min EPS beat(4)-6.76%
Max EPS beat(4)2.3%
EPS beat(8)2
Avg EPS beat(8)-16.79%
EPS beat(12)2
Avg EPS beat(12)-31.23%
EPS beat(16)3
Avg EPS beat(16)-31.08%
Revenue beat(2)2
Avg Revenue beat(2)16.61%
Min Revenue beat(2)3.69%
Max Revenue beat(2)29.53%
Revenue beat(4)2
Avg Revenue beat(4)1.76%
Min Revenue beat(4)-15.93%
Max Revenue beat(4)29.53%
Revenue beat(8)4
Avg Revenue beat(8)4.87%
Revenue beat(12)7
Avg Revenue beat(12)3.98%
Revenue beat(16)9
Avg Revenue beat(16)2.72%
PT rev (1m)1.52%
PT rev (3m)10.33%
EPS NQ rev (1m)-0.98%
EPS NQ rev (3m)-0.52%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)2.17%
Revenue NQ rev (3m)4.84%
Revenue NY rev (1m)5.67%
Revenue NY rev (3m)5.67%
Valuation
Industry RankSector Rank
PE 26.77
Fwd PE 22.64
P/S 19.12
P/FCF N/A
P/OCF 23.52
P/B 2.05
P/tB 2.05
EV/EBITDA 22.69
EPS(TTM)1.37
EY3.74%
EPS(NY)1.62
Fwd EY4.42%
FCF(TTM)-4.8
FCFYN/A
OCF(TTM)1.56
OCFY4.25%
SpS1.92
BVpS17.89
TBVpS17.89
PEG (NY)0.34
PEG (5Y)2.37
Graham Number23.48
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 6.53%
ROCE 5.8%
ROIC 4.58%
ROICexc 5.36%
ROICexgc 5.36%
OM 66.5%
PM (TTM) 60.84%
GM 99.38%
FCFM N/A
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
ROICexc(3y)5.66%
ROICexc(5y)5.62%
ROICexgc(3y)5.66%
ROICexgc(5y)5.62%
ROCE(3y)6.63%
ROCE(5y)6.75%
ROICexgc growth 3Y-3.12%
ROICexgc growth 5Y0.18%
ROICexc growth 3Y-3.12%
ROICexc growth 5Y0.18%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 2.44
Cap/Depr 1743.27%
Cap/Sales 331.26%
Interest Coverage 8.45
Cash Conversion 95.06%
Profit Quality N/A
Current Ratio 4.05
Quick Ratio 4.05
Altman-Z 4.71
F-Score5
WACC8.67%
ROIC/WACC0.53
Cap/Depr(3y)658.62%
Cap/Depr(5y)503.99%
Cap/Sales(3y)134.69%
Cap/Sales(5y)112.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.28%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%66.67%
EPS Next Y78.09%
EPS Next 2Y40.56%
EPS Next 3Y27.76%
EPS Next 5YN/A
Revenue 1Y (TTM)59.24%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%71.16%
Revenue Next Year53.72%
Revenue Next 2Y39.87%
Revenue Next 3Y30.36%
Revenue Next 5YN/A
EBIT growth 1Y62.06%
EBIT growth 3Y21.72%
EBIT growth 5Y16.53%
EBIT Next Year188.71%
EBIT Next 3Y61.38%
EBIT Next 5Y44.17%
FCF growth 1Y-1581.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y138.87%
OCF growth 3Y15.9%
OCF growth 5Y14.1%

CARETRUST REIT INC / CTRE FAQ

What is the fundamental rating for CTRE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CTRE.


Can you provide the valuation status for CARETRUST REIT INC?

ChartMill assigns a valuation rating of 4 / 10 to CARETRUST REIT INC (CTRE). This can be considered as Fairly Valued.


What is the profitability of CTRE stock?

CARETRUST REIT INC (CTRE) has a profitability rating of 8 / 10.


What is the valuation of CARETRUST REIT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CARETRUST REIT INC (CTRE) is 26.77 and the Price/Book (PB) ratio is 2.05.


What is the expected EPS growth for CARETRUST REIT INC (CTRE) stock?

The Earnings per Share (EPS) of CARETRUST REIT INC (CTRE) is expected to grow by 78.09% in the next year.